Order Article Reprints

Alrumaihi F, Khan MA, Babiker AY, Alsaweed M, Azam F, Allemailem KS, Almatroudi AA, Ahamad SR, Alsugoor MH, Alharbi KN, et al. Lipid-Based Nanoparticle Formulation of Diallyl Trisulfide Chemosensitizes the Growth Inhibitory Activity of Doxorubicin in Colorectal Cancer Model: A Novel In Vitro, In Vivo and In Silico Analysis. Molecules. 2022; 27(7):2192. https://doi.org/10.3390/molecules27072192

Alrumaihi, Faris, Masood Alam Khan, Ali Yousif Babiker, Mohammed Alsaweed, Faizul Azam, Khaled S. Allemailem, Ahmad A. Almatroudi, Syed Rizwan Ahamad, Mahdi H. Alsugoor, Khloud Nawaf Alharbi, and et al. 2022. "Lipid-Based Nanoparticle Formulation of Diallyl Trisulfide Chemosensitizes the Growth Inhibitory Activity of Doxorubicin in Colorectal Cancer Model: A Novel In Vitro, In Vivo and In Silico Analysis" Molecules 27, no. 7: 2192. https://doi.org/10.3390/molecules27072192

Alrumaihi, F., Khan, M. A., Babiker, A. Y., Alsaweed, M., Azam, F., Allemailem, K. S., Almatroudi, A. A., Ahamad, S. R., Alsugoor, M. H., Alharbi, K. N., Almansour, N. M., & Khan, A. (2022). Lipid-Based Nanoparticle Formulation of Diallyl Trisulfide Chemosensitizes the Growth Inhibitory Activity of Doxorubicin in Colorectal Cancer Model: A Novel In Vitro, In Vivo and In Silico Analysis. Molecules, 27(7), 2192. https://doi.org/10.3390/molecules27072192